CMS recently issued a final rule cementing hospital Conditions of Participation (CoP) requirements for facilities that transfuse blood and blood components, but the new requirements should be business as usual for hospitals, says Mark S. Lifshitz, MD, clinical professor and director of clinical laboratories at New York University Medical Center in New York City.